We serve Chemical Name:Dimethyl Octadecanedioate CAS:1472-93-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Dimethyl Octadecanedioate
CAS.NO:1472-93-1
Synonyms:dimethyl 1,18-octadecanedioate;Octadecandisaeure-dimethylester;Octadecanedioic acid,dimethyl ester
Molecular Formula:C20H38O4
Molecular Weight:342.51300
HS Code:2917190090
Physical and Chemical Properties:
Melting point:60ºC
Boiling point:207ºC / 3mmHg
Density:0.936g/cm3
Index of Refraction:1.449
PSA:52.60000
Exact Mass:342.27700
LogP:5.57400
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like dimethyl 1,18-octadecanedioate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Octadecanedioic acid,dimethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Octadecandisaeure-dimethylester Use and application,Octadecanedioic acid,dimethyl ester technical grade,usp/ep/jp grade.
Related News: UQUIFA is a manufacturer of APIs and intermediates for the pharmaceutical industry globally. The company has 3 manufacturing sites (2 in Spain and 1 in Mexico) with strict adherence to all regulatory norms. tert-butyl (S)-(1-(naphthalen-1-yl)-3-((2-(trimethylsilyl)ethoxy)methoxy)propan-2-yl)carbamate manufacturers By integrating biocatalysis into ongoing and newly launched projects, Wavelength Pharmaceuticals has shown that it is possible to reduce overall costs by as much as 30%. 4-Oxazolecarboxylic acid, 2-(dichloromethyl)-5-methyl-, ethyl ester suppliers So-called “off” periods occur when a Parkinson’s patient has difficulty moving about and occur when the effect of the last dose of another common Parkinson’s drug, known as levodopa, wears off. rel-(4R,6aS)-4-hydroxy-3-(trimethylgermyl)-4,5,6,6a-tetrahydropentalen-2(1H)-one vendor & factory UQUIFA is a manufacturer of APIs and intermediates for the pharmaceutical industry globally. The company has 3 manufacturing sites (2 in Spain and 1 in Mexico) with strict adherence to all regulatory norms. ,The manufacturing chief pointed to some of the cutting-edge technology Takeda will roll out at the upgraded facility, such as automation and robotics, plus virtual reality equipment and training.
